Download App

Log in to access Online Inquiry
Company Overview More
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
CEO: Stack, David M.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > PCRX Pacira BioSciences > Detailed Quotes

PCRX Pacira BioSciences

60.650-2.460-3.90%
Close 05/24 18:00 ET
60.65000.00%
Post Mkt Price 05/24 16:00 ET
High
62.480
Open
62.200
Turnover
20.81M
Low
60.030
Pre Close
63.110
Volume
342.45K
Market Cap
2.76B
P/E(TTM)
72.20
52wk High
82.160
Shares
45.44M
P/E(Static)
65.92
52wk Low
45.050
Float Cap
2.65B
Bid/Ask %
0.00%
Historical High
121.950
Shs Float
43.70M
Volume Ratio
0.90
Historical Low
6.160
Dividend TTM
--
Div Yield TTM
1800
P/B
3.88
Dividend LFY
--
Div Yield LFY
2967.85%
Turnover Ratio
0.78%
Amplitude
3.88%
Avg Price
60.778
Lot Size
1
Float Cap
2.65B
Bid/Ask %
0.00%
Historical High
121.950
Shs Float
43.70M
Volume Ratio
0.90
Historical Low
6.160
Dividend TTM
--
P/B
3.88
Dividend LFY
--
Turnover Ratio
0.78%
Amplitude
3.88%
Avg Price
60.778
Lot Size
1
Price Forecast

No Data

News

Comment